Incorporation of human iPSC-derived stromal cells creates a pancreatic cancer organoid with heterogeneous cancer-associated fibroblasts
Cell Reports · 2023-11 · 42 (11) · 113420
DOI: 10.1016/j.celrep.2023.113420 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2023-11. Verfasst von Kenta Takeuchi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Cancer-Associated Fibroblasts, Induced Pluripotent Stem Cells, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development, Princess Takamatsu Cancer Research Fund.
Abstract (Originalsprache)
The aggressiveness of pancreatic ductal adenocarcinoma (PDAC) is affected by the tumor microenvironment (TME). In this study, to recapitulate the PDAC TME ex vivo, we cocultured patient-derived PDAC cells with mesenchymal and vascular endothelial cells derived from human induced pluripotent stem cells (hiPSCs) to create a fused pancreatic cancer organoid (FPCO) in an air-liquid interface. FPCOs were further induced to resemble two distinct aspects of PDAC tissue. Quiescent FPCOs were drug resistant, likely because the TME consisted of abundant extracellular matrix proteins that were secreted from the various types of cancer-associated fibroblasts (CAFs) derived from hiPSCs. Proliferative FPCOs could re-proliferate after anticancer drug treatment, suggesting that this type of FPCO would be useful for studying PDAC recurrence. Thus, we generated PDAC organoids that recapitulate the heterogeneity of PDAC tissue and are a potential platform for screening anticancer drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
- Division of Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
- Division of Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Graduate School of Frontier Sciences, Computational Biology and Medical Science, Kashiwa, Chiba, Japan.
- Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan; Department of Regenerative Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
- Division of Clinical Genome Research, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
- Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
Förderung
- Japan Agency for Medical Research and Development
- Princess Takamatsu Cancer Research Fund
Zitieren
APA
Takeuchi, K., Tabe, S., Takahashi, K., Aoshima, K., Matsuo, M., Ueno, Y., Furukawa, Y., Yamaguchi, K., Ohtsuka, M., Morinaga, S., Miyagi, Y., Yamaguchi, T., Tanimizu, N., & Taniguchi, H. (2023). Incorporation of human iPSC-derived stromal cells creates a pancreatic cancer organoid with heterogeneous cancer-associated fibroblasts. Cell Reports, 42(11), 113420. https://doi.org/10.1016/j.celrep.2023.113420
Vancouver
Takeuchi K, Tabe S, Takahashi K, Aoshima K, Matsuo M, Ueno Y, et al. Incorporation of human iPSC-derived stromal cells creates a pancreatic cancer organoid with heterogeneous cancer-associated fibroblasts. Cell Reports. 2023;42(11):113420. doi:10.1016/j.celrep.2023.113420
BibTeX
@article{Takeuchi2023,
author = {Takeuchi, Kenta and Tabe, Shunsuke and Takahashi, Kenta and Aoshima, Kenji and Matsuo, Megumi and Ueno, Yasuharu and Furukawa, Yoichi and Yamaguchi, Kiyoshi and Ohtsuka, Masayuki and Morinaga, Soichiro and Miyagi, Yohei and Yamaguchi, Tomoyuki and Tanimizu, Naoki and Taniguchi, Hideki},
title = {Incorporation of human iPSC-derived stromal cells creates a pancreatic cancer organoid with heterogeneous cancer-associated fibroblasts},
journal = {Cell Reports},
year = {2023},
volume = {42},
number = {11},
pages = {113420},
doi = {10.1016/j.celrep.2023.113420}
}
EUVIMED